Celldex Therapeutics (CLDX) Operating Expenses (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Operating Expenses of $84.4 million for Q1 2026, up 33.13% year-over-year from $63.4 million in Q1 2025, and down 3.24% quarter-over-quarter from $87.3 million in Q4 2025.
Celldex Therapeutics (CLDX) Operating Expenses (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Operating Expenses history runs 17 years deep, the most recent figure standing at $84.4 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 33.13% year-over-year to $84.4 million; the TTM figure through Mar 2026 stood at $309.9 million (up 37.89% YoY), while the FY2025 annual figure was $288.9 million, up 42.96% from the prior year.
- Operating Expenses for Q1 2026 stood at $84.4 million, down from $87.3 million in the prior quarter.
- The five-year high for Operating Expenses was $87.3 million in Q4 2025, with the low at $23.4 million in Q1 2022.
- The 5-year median for Operating Expenses is $48.8 million (2024), against an average of $50.3 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses jumped 116.07% in 2022, then fell 8.44% in 2023.
- Celldex Therapeutics' Operating Expenses stood at $29.5 million in 2022, then soared by 75.46% to $51.8 million in 2023, then grew by 10.52% to $57.2 million in 2024, then jumped by 52.57% to $87.3 million in 2025, then fell by 3.24% to $84.4 million in 2026.
- Business Quant data shows CLDX's Operating Expenses at $84.4 million in Q1 2026, $87.3 million in Q4 2025, and $73.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | 80.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 80.65 Mn |
| Mar 31, 2026 | 84.45 Mn |
| Dec 31, 2025 | 87.27 Mn |
| Sep 30, 2025 | 73.62 Mn |
| Jun 30, 2025 | 64.59 Mn |
| Mar 31, 2025 | 63.43 Mn |
| Dec 31, 2024 | 57.20 Mn |
| Sep 30, 2024 | 55.32 Mn |
| Jun 30, 2024 | 48.82 Mn |
| Mar 31, 2024 | 40.76 Mn |
| Dec 31, 2023 | 51.76 Mn |
| Sep 30, 2023 | 42.76 Mn |
| Jun 30, 2023 | 33.47 Mn |
| Mar 31, 2023 | 33.44 Mn |
| Dec 31, 2022 | 29.50 Mn |
| Sep 30, 2022 | 28.10 Mn |
| Jun 30, 2022 | 36.56 Mn |
| Mar 31, 2022 | 23.43 Mn |
| Dec 31, 2021 | 20.67 Mn |
| Sep 30, 2021 | 20.98 Mn |